Top Page
Barclays
(LSE:BARC)
Barclays (BARC) vs. S&P 500 (SPY)
Barclays Business Overview & Revenue Model
Barclays Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 25.43B | 26.23B | 23.50B | 24.96B | 21.94B | 21.77B | Gross Profit |
| 25.43B | 26.23B | 25.38B | 24.96B | 21.94B | 21.77B | EBIT |
| 4.14B | 0.00 | 7.42B | 15.49B | 8.37B | 2.99B | EBITDA |
| 2.06B | 0.00 | 0.00 | 8.73B | 9.61B | 4.60B | Net Income Common Stockholders |
| 4.97B | 6.31B | 5.26B | 5.93B | 7.01B | 2.38B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 220.88B | 210.18B | 220.88B | 256.35B | 238.57B | 191.13B | Total Assets |
| 1.48T | 1.52T | 1.48T | 1.51T | 1.38T | 1.35T | Total Debt |
| 150.55B | 0.00 | 150.55B | 124.30B | 111.63B | 92.14B | Net Debt |
| -70.33B | -210.18B | -70.33B | -132.05B | -126.95B | -98.99B | Total Liabilities |
| 1.41T | 1.45T | 1.41T | 1.44T | 111.63B | 92.14B | Stockholders Equity |
| 71.20B | 71.82B | 71.20B | 68.29B | 69.22B | 65.80B |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | 5.54B | -2.65B | 28.48B | 47.20B | 56.18B | Operating Cash Flow |
| 0.00 | 7.11B | -927.00M | 30.23B | 48.92B | 57.51B | Investing Cash Flow |
| 0.00 | -17.89B | -23.41B | -21.67B | 4.27B | -18.38B | Financing Cash Flow |
| 0.00 | 784.00M | -8.35B | 696.00M | 107.00M | 2.73B |
Barclays Technical Analysis
Barclays Risk Analysis
Barclays Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £157.91B | 9.07 | 13.62% | 5.46% | 3.98% | 5.43% | |
78 Outperform | £44.12B | 8.43 | 9.03% | 2.77% | 5.56% | 31.39% | |
75 Outperform | £42.64B | 11.22 | 9.84% | 4.01% | 31.97% | -21.96% | |
71 Outperform | £37.28B | 8.65 | 13.18% | 3.78% | 15.69% | 11.47% | |
64 Neutral | $14.60B | 10.27 | 8.71% | 4.21% | 16.53% | -11.93% |
Barclays Earnings Call Summary
Barclays Corporate Events
Barclays PLC has announced the purchase and cancellation of 2,865,000 of its ordinary shares as part of a buy-back program initiated on 14 February 2025. This move is part of Barclays’ ongoing strategy to optimize its capital structure and return value to shareholders, with the total number of shares repurchased since the program’s commencement reaching 100,175,686.
Barclays PLC has disclosed its opening position in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals Barclays’ interests and short positions in Dalata’s securities, highlighting a total interest of 1.20% and short positions of 1.22%. This move is significant as it reflects Barclays’ strategic positioning and potential influence in the ongoing dealings related to Dalata Hotel Group, which could impact stakeholders and market dynamics.
Barclays PLC has announced the purchase and cancellation of 2,892,540 of its ordinary shares as part of a buy-back program initiated on 14 February 2025. This move is expected to reduce the total number of shares in circulation, potentially increasing the value of remaining shares and affecting shareholder calculations under FCA’s rules.
Barclays PLC has announced the purchase and cancellation of 2,065,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move reduces the company’s share capital to 14,345,792,660 ordinary shares, potentially impacting shareholder interests and aligning with regulatory requirements.
Barclays PLC has disclosed its opening position in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds interests and short positions in Dalata’s securities, with a total of 2,389,196 shares representing 1.13% and short positions totaling 2,426,614 shares or 1.15%. This announcement is part of regulatory compliance and may impact stakeholders by indicating Barclays’ strategic interests in the hospitality sector.
Barclays PLC announced the purchase and cancellation of 2,015,000 ordinary shares as part of its ongoing share buy-back program, initially announced in February 2025. This move aims to reduce the number of shares in circulation, potentially increasing shareholder value and consolidating the company’s market position. The cancellation will adjust the company’s issued share capital to 14,347,795,836 ordinary shares with voting rights, impacting shareholders’ notification obligations under FCA rules.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC as part of the Irish Takeover Panel’s regulatory requirements. The disclosure indicates Barclays’ interests and short positions in Dalata’s securities, reflecting a total of 1.12% in interests and 1.14% in short positions. This announcement is part of the regulatory compliance process and may impact stakeholders by providing transparency about Barclays’ investment activities in Dalata, potentially influencing market perceptions and investor decisions.
Barclays PLC has executed a share buy-back program, purchasing 2.9 million of its ordinary shares for cancellation on the London Stock Exchange. This move is part of a larger buy-back initiative announced in February 2025, aimed at reducing the total number of shares outstanding, which now stands at approximately 14.35 billion. This strategic action is expected to enhance shareholder value and optimize the company’s capital structure.
Barclays PLC has disclosed its dealings and positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 1.18% interest in Dalata’s relevant securities and has engaged in various purchase and sale transactions. This disclosure is part of regulatory compliance and provides transparency regarding Barclays’ investment activities, which could impact its strategic positioning in the market.
Barclays PLC has repurchased and canceled 5.1 million of its ordinary shares as part of its ongoing buy-back program announced in February 2025. This move is part of a broader strategy to manage the company’s capital structure, potentially enhancing shareholder value and adjusting the number of shares with voting rights to 14.35 billion. The buy-back reflects Barclays’ commitment to optimizing its financial framework and could influence shareholder interests and market perceptions.
Barclays PLC has disclosed its current position in Dalata Hotel Group PLC, revealing ownership and control of 1.19% of relevant securities and 1.20% in short positions. This disclosure, required under Rule 8.3 of the Irish Takeover Panel Act, highlights Barclays’ strategic financial maneuvers within the hospitality sector, potentially impacting its market positioning and stakeholder interests.
Barclays PLC has announced changes to its board of directors, with Tim Breedon retiring and Diony Lebot and Mary Mack being appointed as non-executive directors. These appointments aim to enhance the board’s expertise in European markets and consumer banking, aligning with Barclays’ strategic growth objectives. Breedon, who has been with Barclays for over 12 years, will continue as Chair of Barclays Bank Ireland PLC. Lebot brings extensive experience from her tenure at Société Générale, while Mack offers a wealth of knowledge from her career at Wells Fargo.
Barclays PLC announced the repurchase and cancellation of 5,240,000 ordinary shares as part of its ongoing buy-back program. This move is part of a broader strategy to optimize capital structure and return value to shareholders, impacting the company’s share capital and potentially influencing shareholder interest notifications.
Barclays PLC announced transactions involving its managerial staff, specifically the receipt and disposal of shares and American Depositary Shares (ADSs). Group Chief Executive C.S. Venkatakrishnan received ADSs following a conversion of shares, while Global Co-Head of Investment Banking Cathal Deasy disposed of shares through Solium Capital UK Limited. These transactions reflect internal movements of shares and may impact the company’s stock management and stakeholder interests.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure reveals Barclays’ ownership and control of relevant securities, including cash-settled derivatives, with a total interest of 1.27% and short positions of 1.28%. This announcement is part of regulatory compliance and provides transparency regarding Barclays’ financial interests in Dalata Hotel Group, potentially impacting stakeholders’ perceptions and the company’s strategic positioning in the market.
Barclays PLC has executed a share buy-back program, purchasing 3,010,000 ordinary shares for cancellation on the London Stock Exchange, as part of its initiative announced in February 2025. This move reduces the total issued share capital to 14,362,855,210 shares, potentially impacting shareholder calculations under FCA rules and reflecting the company’s strategic financial management to enhance shareholder value.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC as part of the Irish Takeover Panel’s requirements. The disclosure reveals Barclays’ interests and short positions in Dalata’s securities, highlighting a total interest of 1.27% and short positions of 1.28%. This announcement is significant as it provides transparency about Barclays’ investment activities and may influence stakeholder perceptions regarding its strategic interests in the hospitality sector.
Barclays PLC announced the repurchase and cancellation of 2,090,000 ordinary shares as part of its ongoing buy-back program, which began on 14 February 2025. This move is intended to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests by altering voting rights and share value calculations.
Barclays PLC announced the repurchase and cancellation of 3,050,000 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating the company’s confidence in its financial health. The total issued share capital post-cancellation will consist of 14,367,863,924 ordinary shares with voting rights, which stakeholders can use for notification obligations under FCA rules.
Barclays PLC announced transactions involving its managerial staff’s share awards under various company plans. The company detailed the allocation of shares as part of deferred remuneration for 2024, the delivery of shares for non-deferred remuneration, and shares related to fixed remuneration and long-term incentive plans. These transactions reflect Barclays’ ongoing commitment to aligning managerial compensation with performance and shareholder interests, potentially impacting stakeholder perceptions and the company’s market positioning.
Barclays PLC has announced the repurchase and cancellation of 5,411,861 of its ordinary shares on the London Stock Exchange, as part of a buy-back program initiated in February 2025. This move is part of a larger strategy to manage its share capital, having repurchased a total of 68,948,146 shares since the program’s commencement, potentially impacting shareholder value and market perception.
Barclays PLC has announced the publication of its Base Prospectus for the Debt Issuance Programme, which has been approved by the Financial Conduct Authority. This development signifies Barclays’ ongoing efforts to maintain transparency and regulatory compliance in its financial operations, potentially impacting its market positioning and providing stakeholders with updated information on its debt issuance activities.
Barclays PLC has announced the publication of an Information Memorandum for its AUD Debt Issuance Programme, which has been submitted to the International Securities Market. This move is part of Barclays’ strategic efforts to enhance its funding capabilities and strengthen its financial position in the market, potentially impacting its stakeholders by offering new investment opportunities.
Barclays PLC has announced the purchase and cancellation of 5,155,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move is part of a broader strategy to manage the company’s capital structure and potentially enhance shareholder value, with implications for voting rights and share capital calculations.
Barclays PLC has repurchased 2,008,000 of its ordinary shares from J.P. Morgan Securities plc as part of its ongoing share buy-back program announced in February 2025. The repurchased shares will be cancelled, reducing the company’s issued share capital to 14,381,428,537 ordinary shares. This move is part of Barclays’ strategy to enhance shareholder value and optimize its capital structure.
Barclays PLC announced the purchase and cancellation of 5,267,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move, conducted through J.P. Morgan Securities plc, aims to reduce the company’s share capital and potentially enhance shareholder value. Following this transaction, Barclays’ issued share capital now consists of 14,372,346,584 ordinary shares, which stakeholders can use to assess their interests under regulatory guidelines.
Barclays PLC has announced the repurchase and cancellation of 1,961,000 of its ordinary shares as part of its ongoing buy-back program initiated on 14 February 2025. This move is part of a broader strategy to manage its capital structure and enhance shareholder value, with a total of 46,031,285 shares purchased since the program’s inception. The cancellation of these shares will adjust the company’s issued share capital to 14,377,584,418 ordinary shares, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has announced the repurchase and cancellation of 2,827,000 of its ordinary shares on the London Stock Exchange, as part of a buy-back program initiated on 14 February 2025. This move, which follows the purchase of over 44 million shares since the program’s commencement, aims to reduce the company’s share capital and potentially enhance shareholder value by increasing the proportionate ownership of remaining shares.
Barclays PLC announced that as of 28 February 2025, its issued share capital consists of 14,382,253,906 ordinary shares with voting rights, with none held in treasury. This figure is crucial for shareholders and those with notification obligations to determine their interest in Barclays under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has applied for the block listing of 20 million ordinary shares on the London Stock Exchange, under its Group Share Value Plan. The shares, which will rank equally with existing shares, are expected to be admitted for trading on March 4, 2025, potentially enhancing the company’s market liquidity and shareholder value.
Barclays PLC has announced the purchase and cancellation of 2,885,000 of its ordinary shares on the London Stock Exchange as part of its ongoing buy-back program. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with a total of 41,243,285 shares repurchased since the program’s commencement, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has executed a share buy-back program, purchasing 2,848,500 of its ordinary shares for cancellation, as part of a previously announced initiative. This move reduces the company’s issued share capital to 14,385,107,275 shares, potentially impacting shareholder calculations under the FCA’s rules, and reflects Barclays’ strategic efforts to manage its equity structure.
Barclays PLC announced a transaction involving the disposal of shares by Taylor Wright, the Global Co-Head of Investment Banking, as part of the company’s nominee service managed by Solium Capital UK Limited. The transaction, which involved 27,163 shares at a price of £3.017 each, took place on the London Stock Exchange and reflects ongoing managerial activities within the company, potentially impacting shareholder perceptions and market dynamics.
Barclays PLC announced the repurchase and cancellation of 5,185,000 of its ordinary shares as part of its ongoing buy-back program. This move, aimed at reducing the number of shares in circulation, will adjust the company’s issued share capital to 14,387,920,127 ordinary shares with voting rights, potentially impacting shareholder calculations and interests under regulatory guidelines.
Barclays PLC has announced the availability of a prospectus supplement related to the issuance of $1.5 billion in 7.625% Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities. This financial move is part of Barclays’ strategy to strengthen its capital base and enhance its financial flexibility, potentially impacting its market positioning and offering implications for investors and stakeholders.
Barclays PLC has executed a share buy-back program, purchasing 5.1 million of its own shares for cancellation, as part of an initiative announced earlier in February 2025. This move is aimed at reducing the total number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. The cancellation of these shares will adjust the company’s issued share capital to approximately 14.4 billion shares, which stakeholders can use for regulatory notification purposes.
Barclays PLC announced the purchase and cancellation of 5,100,000 of its ordinary shares as part of its buy-back program. This move is part of a broader strategy to manage its share capital and could potentially impact shareholder value by reducing the number of shares in circulation, thus increasing the value of remaining shares.
Barclays PLC announced the repurchase of 2,871,846 of its ordinary shares on the London Stock Exchange, as part of its ongoing buy-back program initiated on 14 February 2025. This move is expected to reduce the company’s share capital to 14,406,016,158 shares and could potentially enhance shareholder value by decreasing the number of shares in circulation.
Barclays PLC has announced the purchase and cancellation of 1,980,000 ordinary shares as part of its ongoing share buy-back program, which began on 14 February 2025. This move aims to reduce the company’s share capital, thereby potentially increasing shareholder value and adjusting the denominator for shareholder interest calculations under regulatory guidelines.
Barclays PLC announced the repurchase and cancellation of 1,986,825 of its ordinary shares from J.P. Morgan Securities plc as part of its ongoing buy-back program. This move, which follows a previous announcement on 14 February 2025, reduces the company’s issued share capital to 14,410,729,298 ordinary shares. The buy-back program aims to enhance shareholder value and optimize the capital structure of the company, reflecting Barclays’ commitment to returning excess capital to shareholders while maintaining regulatory compliance.
Barclays PLC announced the acquisition of shares by its Non-Executive Directors and Group Chairman as part of their compensation policy. This policy involves using a portion of the directors’ fees to purchase shares, which are retained until they leave the board, aligning their interests with those of shareholders. The transactions were conducted on the London Stock Exchange, and this approach aims to enhance stakeholder alignment and strengthen corporate governance by ensuring that directors have a vested interest in the company’s performance.
Barclays PLC announced the purchase and cancellation of 5.1 million of its ordinary shares as part of its ongoing buy-back program, which commenced on 14 February 2025. This strategic move is aimed at reducing the total share count to 14.4 billion shares, potentially enhancing shareholder value and reflecting the company’s confidence in its financial health and future prospects.
Barclays PLC has announced the repurchase and cancellation of over 5 million of its ordinary shares as part of a buy-back program. This move is expected to reduce the total number of shares in circulation, allowing shareholders to adjust their stakes and maintain compliance with regulatory guidelines, potentially impacting share value positively.
Barclays PLC has filed its 2024 Annual Report on Form 20-F with the US Securities and Exchange Commission, making it available online and through the National Storage Mechanism for inspection. This filing ensures transparency and accessibility of Barclays’ financial performance and operations to its shareholders, including those holding American Depositary Receipts, who can request audited financial statements at no charge.
Barclays PLC has announced the commencement of a £1,000 million share buy-back program starting 14 February 2025, with the goal of reducing its share capital. J.P. Morgan Securities plc will conduct the buy-back on behalf of Barclays, making independent trading decisions within regulatory parameters. This initiative is set to conclude by 13 November 2025, contingent on regulatory approval, and reflects Barclays’ strategic financial management efforts to enhance shareholder value.
Barclays has released its 2024 Annual Report and Accounts, along with the 2024 Pillar 3 Report. These documents are now available for inspection through the National Storage Mechanism and the company’s website. This release is part of Barclays’ efforts to maintain transparency with its stakeholders and complies with regulatory requirements. The reports provide comprehensive insights into the company’s financial performance and governance practices for the year 2024.
Barclays PLC announced its 2024 financial results, achieving a return on tangible equity of 10.5% and distributing £3.0 billion in capital, including a £1.0 billion buyback. The company saw a 24% increase in profit before tax to £8.1 billion and an earnings per share rise of 8.3p to 36.0p, demonstrating successful execution of its three-year plan and aligning with its 2026 targets.
Barclays PLC has announced its total issued share capital, which consists of 14,421,517,527 ordinary shares with voting rights as of January 31, 2025. This information is crucial for shareholders and entities with notification obligations under the FCA’s Disclosure Guidance, as it serves as the denominator for calculating changes in share interest, thereby impacting investor relations and market transparency.
Barclays PLC has completed the sale of its German consumer finance business to BAWAG P.S.K., a subsidiary of BAWAG Group AG. This strategic move is intended to simplify Barclays’ operations and focus on expanding its key business segments, releasing approximately €4.0bn of risk-weighted assets and increasing the CET1 ratio by about 10 basis points, thus strengthening its financial position.
Barclays has announced changes to its board as part of its long-term succession planning. Diane Schueneman will retire from several key roles, while Brian Shea will take over as Chair of Barclays Execution Services Limited, bringing over 40 years of financial services experience to the position. Additionally, Nigel Higgins, Group Chairman, joins the Board Remuneration Committees, marking further strategic adjustments in the company’s leadership. These changes reflect Barclays’ strategic focus on strengthening its governance and operational leadership, potentially impacting its market positioning and stakeholder relations.
Barclays PLC announced the availability of the final terms for its issuance of GBP 750,000,000 Fixed Rate Resetting Senior Callable Notes due 31 July 2032, as part of the Barclays PLC Debt Issuance Programme. This issuance reflects Barclays’ strategic approach to managing its long-term debt obligations and maintaining a robust capital structure, potentially impacting its financial stability and offering insights into its future operational strategies.
Barclays PLC has announced the full redemption of its EUR 1,000,000,000 1.375% Reset Notes due 2026, effective 24 January 2025. This move includes canceling the Notes’ listing on the FCA Official List and their trading on the London Stock Exchange, indicating a strategic financial decision likely impacting the company’s debt structure and market operations.